CClinicalTrials.gg
RecruitingNCT07769151Updated Aug 17, 2026

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

An observational study in Mortality Prediction, sponsored by Henry Ford Health System. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Henry Ford Health System · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
124
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

02

Conditions studied

  • Mortality Prediction
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients >18 year old planned for SCTCT

Inclusion criteria

  • patients >18 year old planned for SCTCT

Exclusion criteria

Exclusion Criteria:

  • Pregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
124 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testblood sample to check CXCL9 pre stem cell transplant and cell therapy

    Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

05

What researchers measure

Primary outcomes

  1. Non relapse mortality (NRM)

    Time frame: NRM at day 100 and at year 1

06

Study locations

1 of 1 sites recruiting
  • Henry Ford Health
    Detroit, Michigan 48202, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07769151
Lead sponsor
Henry Ford Health System
Responsible party
Sponsor
First posted
Aug 17, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 30, 2030 (estimated)
Completion
Dec 30, 2031 (estimated)
Last update
Aug 17, 2026

Study contacts

Shatha Farhan, MD
Contact
sfarhan1@hfhs.org
3137133910
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion